Pediatric Asthma Controller Trial (PACT)

This study has been completed.
Sponsor:
Collaborator:
Childhood Asthma Research and Education Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00272506
First received: January 3, 2006
Last updated: July 10, 2006
Last verified: January 2006
  Purpose

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.


Condition Intervention Phase
Asthma
Lung Diseases
Drug: inhaled corticosteroid
Drug: long-acting beta2-agonist
Phase 3

Study Type: Interventional
Study Design: Intervention Model: Crossover Assignment
Primary Purpose: Treatment

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: August 2002
Estimated Study Completion Date: September 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00272506

Sponsors and Collaborators
Childhood Asthma Research and Education Network
Investigators
Investigator: Vernon Chinchilli Milton S. Hershey Medical Center
Investigator: Robert Lemanske University of Wisconsin, Madison
Investigator: Fernando Martinez University of Arizona
Investigator: Robert Strunk Washington University Early Recognition Center
Investigator: Stanley Szefler National Jewish Health
Investigator: Robert Zeiger University of California, San Diego
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00272506     History of Changes
Other Study ID Numbers: 351
Study First Received: January 3, 2006
Last Updated: July 10, 2006
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Asthma
Lung Diseases
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 29, 2014